Reaxys chemical database trial

No Comments »

Elsevier is providing UMass Lowell with a one month free trial to their Reaxys database. The trial is available from April 14 to May 14, 2011.

Reaxys is a unique web-based chemistry workflow solution which integrates searches for reaction and substance data with synthesis planning and chemical sourcing. It contains historical data dating back to 1771 and coverage of important current journal and patents within chemistry. The data excerpted from the journals and patents meets carefully controlled selection criteria – namely that all organic, inorganic and organometallic properties and data are excerpted only if they have a structure, experimental fact and a credible citation.

The reaction and substance data within Reaxys is experimentally validated – not calculated – so that less time is spent interrogating results. Its synthesis planner supports the evaluation of alternative synthetic routes and allows chemists to identify and combine selected reaction steps. Sophisticated relevance ranking algorithms combine with filtering tools help prevent chemists from reading irrelevant articles and pursuing unsubstantiated references.

Enhanced interoperability between Reaxys and ScienceDirect further improves the discoverability and visualization of chemical structures. To further improve discoverability and usefulness of the chemistry, authors submitting articles to selected journals are invited to contribute structure (MOL) files of their key compounds. These structure files will be used to visually display all the key compounds referenced in the article in a single scrollable list and will contain direct links to Reaxys, straight from ScienceDirect. It is already possible to access the full-text literature from Reaxys; now Reaxys content is available from ScienceDirect, completing the circle. Furthermore compound identifiers (InChI keys) will be added to the structures, making both the article and its key compounds more discoverable through mainstream search engines like Google.

More information is available here:

Access to this trial is available through the library’s New Database Trials and Subscriptions webpage.

Please post comments concerning any aspect of this trial; it aids significantly in our decision-making process.

Leave a Reply